Targeting DOT1L May Reverse Leukemogenic Effects of Mutant DNMT3A [Leukemia]

Mutant DNMT3A promotes leukemogenesis via aberrant epigenetic induction of stem-cell genes.

from Cancer via ola Kala on Inoreader http://ift.tt/2arSH0u
via IFTTT